Evidence map›Paper›PMID 29693598›Full record

ArticleNutrients2018

Inulin Improves Postprandial Hypertriglyceridemia by Modulating Gene Expression in the Small Intestine.

Sophie Hiel, Audrey M Neyrinck, Julie Rodriguez, Barbara D Pachikian, Caroline Bouzin, Jean-Paul Thissen, Patrice D Cani, Laure B Bindels, Nathalie M Delzenne

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04611217 (Mechanisms Linking Dietary Fiber, the Microbiome and Satiety), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04611217 narecruitingnot on this mapstarted 2021, after this paper: background citation

Mechanisms Linking Dietary Fiber, the Microbiome and Satiety

TypeinterventionalSponsorUniversity of Missouri-ColumbiaRan2021 to 2025Enrolled88ConditionsDietary FiberArmsDietary fiber: 10-25g, Dietary fiber: 5g
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Inulin may inhibit ADAM17 to delay atherosclerosis.Open medicine (Warsaw, Poland) · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sophie HielMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200 Brussels, Belgium. sophie.hiel@uclouvain.be.
Audrey M NeyrinckMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200 Brussels, Belgium. audrey.neyrinck@uclouvain.be.ORCID 0000-0002-9435-3338
Julie RodriguezMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200 Brussels, Belgium. j.rodriguez@uclouvain.be.
Barbara D PachikianMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200 Brussels, Belgium. barbara.pachikian@uclouvain.be.
Caroline Bouzin
Jean-Paul Thissen
Patrice D CaniMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200 Brussels, Belgium. patrice.cani@uclouvain.be.
Laure B BindelsMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200 Brussels, Belgium. laure.bindels@uclouvain.be.
Nathalie M DelzenneMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, B-1200 Brussels, Belgium. nathalie.delzenne@uclouvain.be.ORCID 0000-0002-9435-3338
UCLouvain · BE

Funding

European Research Council 336452
6 · The paper itself

Abstract

Postprandial hyperlipidemia is an important risk factor for cardiovascular diseases in the context of obesity. Inulin is a non-digestible carbohydrate, known for its beneficial properties in metabolic disorders. We investigated the impact of inulin on postprandial hypertriglyceridemia and on lipid metabolism in a mouse model of diet-induced obesity. Mice received a control or a western diet for 4 weeks and were further supplemented or not with inulin for 2 weeks (0.2 g/day per mouse). We performed a lipid tolerance test, measured mRNA expression of genes involved in postprandial lipid metabolism, assessed post-heparin plasma and muscle lipoprotein lipase activity and measured lipid accumulation in the enterocytes and fecal lipid excretion. Inulin supplementation in western diet-fed mice decreases postprandial serum triglycerides concentration, decreases the mRNA expression levels of

Indexed as

Postprandial PeriodAnimalsApolipoprotein C-IIIBiomarkersCD36 AntigensDisease Models, AnimalGene Expression RegulationHypertriglyceridemiaHypolipidemic AgentsIntestine, SmallInulinLipid MetabolismMaleMice, Inbred C57BLObesityRNA, MessengerApolipoprotein C-IIIBiomarkersCD36 AntigensHypolipidemic AgentsInulinRNA, MessengerTriglyceridesinulinobesitypostprandial hypertriglyceridemia

Identifiers

PMID29693598
PMCPMC5986412
OpenAlexW2802447757

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.